Pancreatic Cancer Research

ResearcherJishou UniversityActive in the last 2 years

Zewen Song

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9685-0725; OpenAlex author ID A5036780987. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Machine learning‑based construction of damage‑associated molecular patterns related score identifies subtypes of pancreatic adenocarcinoma with distinct progno… Co-author DOI 10.3892/ol.2025.14992↗
  2. Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma. Last author DOI 10.1016/j.lfs.2021.119462↗
  3. Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature. Last author DOI 10.3389/fcell.2021.649265↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Liang · 1 shared paper, 2025 · strength 0.30
  2. Wenxin Ding · 1 shared paper, 2025 · strength 0.30
  3. Jianfeng Zhang · 1 shared paper, 2025 · strength 0.30
  4. Juan Tan · 2 shared papers, 2021 · strength 0.29
  5. Yang Liu · 2 shared papers, 2021 · strength 0.29
  6. Xi Zhang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.